Please provide your email address to receive an email when new articles are posted on . “Prior research has established the subcutaneous ICD as a reasonable alternative to the transvenous ICD in ...

June 21, 2012 (Nice, France) — The next "disruptive" technology in pacemaker and ICD technology may be devices that do not have any transvenous leads or perhaps no leads at all [1]. The potential for ...

Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...

Patients who require a new permanent pacemaker after TAVI do just as well with leadless devices out to 2 years as they do with transvenous pacemakers, according to an analysis of real-world data from ...

MENLO PARK, Calif.--(BUSINESS WIRE)--BioTrace Medical, Inc., the leader in innovative temporary cardiac pacing technology, today announced the company’s Tempo ® Temporary Pacing Lead was featured in a ...

Typical balloon placement and pretreatment sites relative to pacing/defibrillation leads. Photo Credit: J Am Coll Cardiol EP. Central Illustration (adapted). Pacemaker and defibrillator leads encased ...

Please provide your email address to receive an email when new articles are posted on . Transvenous ICD leads are associated with tricuspid regurgitation compared with subcutaneous ICDs. More research ...

Varices are dilated veins. Gastric varices form in around 20% of people with portal hypertension. Portal hypertension can happen in cirrhosis or in people without cirrhosis who develop thrombosis of ...

A leadless intracardiac transcatheter pacing system has been designed to avoid the need for a pacemaker pocket and transvenous lead.In a prospective multicenter study without controls, a transcathe ...

When transvenous pacing is unsuitable, leadless cardiac pacemaker implantation can be used during the evidence generation period for dual-chamber pacing or right atrial pacing alone for ...